Visiongain launches The Global Respiratory Inhalers Market 2017-2027 report

World News: . []

LONDON, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Where is the market heading? If you are involved in this sector you must read this brand new report. s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

This 181-page report provides 118 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Respiratory Inhalers market. See how to exploit the opportunities.

For the report overview please email Sara Peerun on or call +44 207 549 9987

• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

For the TOC please click on:

Respiratory Inhalers Market Forecasts to 2027, by Product: • Metered Dose Inhalers • Dry Powder Inhalers - Single-Dose DPIs - Multi-Dose DPIs • Nebulizers - Jet / Compressor Nebulizers - Ultrasonic Nebulizers - Vibrating-Mesh Nebulizers

Respiratory Inhalers Market Forecasts to 2027, by Application: • Asthma • COPD • Other Respiratory Diseases

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 12 leading national markets: • The US • The EU5 markets - Germany - France - UK - Italy - Spain

• Japan • China • India • Russia • Brazil • Mexico

The report also includes profiles and forecasts for some of the leading companies in the Respiratory Inhalers device market, with a focus on the Respiratory Inhalers device segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Visiongain’s study is for everybody needing commercial analyses for the Respiratory Inhalers device market and leading companies. You find data, trends and predictions.

 Companies mentioned in this report include:

3M Drug Delivery Systems Actavis Adherium Limited Aerogen Agilent Technology Airssential Allied Healthcare Almirall Astrazeneca Boehringer Ingelheim Briggs Healthcare CareFusion Chiesi Cipla Clement Clarke International Cohero Health DeVilbiss Healthcare Fexicare Gecko Health Innovations GF Health Products GlaxoSmithKline Heyer Medical Hikma Innovate Biomed Inspiro Medical Medline Surgical Merck MRK Healthcare Mylan Nexus 6 Nouvag AG Novartis Omron Healthcare Opko Health Orion Pharma PARI Medical Pfizer Philips Respironics Propeller Health Qualcomm Incorporated Roche Schering-Plough Sunovion Pharma Takeda Pharmaceutical Company Limited Teva Pharmaceuticals Vectura Viatris

More news and information about Visiongain Ltd

Published By:

Globe Newswire: 13:29 GMT Tuesday 14th November 2017

Published: .

Search for other references to "visiongain" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers